Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

The lawsuit alleges marketing fraud against pharmaceutical company Merck for its HPV vaccine, Gardasil, which Merck denies. The Centers for Disease Control and Prevention (CDC) maintains that the ...

He says, if confirmed, he can still earn referral fees from a firm suing Merck ... or HPV -- and later grew sick. Public health researchers and doctors said there was no evidence that the vaccine ...

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is ... by the human papillomavirus, or HPV. Mr. Kennedy took the unusual ...

continues to support the safety and efficacy profiles of our HPV vaccines," Rahway, New Jersey-based Merck said Tuesday in a statement on the litigation. "The plaintiff's allegations have no merit ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Wisner Baum is suing Merck & Co. over allegations that the pharmaceutical company failed to properly warn patients about HPV vaccine risks. The government documents don’t say for which cases ...